Using genetics to discover life-changing biologic medicines
.png){kind=logo}
™
Disrupting & Redefining
Genetic Diagnostics
& Drug Discovery
functional and clinical impact
of all gene mutations
Heligenics believes that people can live healthier lives. We recognize major healthcare problems can be solved through discover to new and better Biologic drugs.
What do others in this industry do?
-
50 years dedicated to single-gene exploration
-
A decade focused on thousands of single cells
-
A strong emphasis on single variants
What sets Heligenics apart?
​​Our solution is the GigaAssay platform, enabling us to:
-
Analyze a million single molecules
-
Examine 500,000,000 cells
-
Evaluate the actions of all gene variants
Explore our deliverables:
-
Innovative Biologics & Biobetters
-
Advanced Double- and Triple-Chimeras
-
Enhanced Diagnostics
-
Accelerated & Improved Companion Diagnostics
-
Truly Precise Clinical Trials
Heligenics analyzes massive Gene Mutation Libraries (GMLs) with our GigaAssay™ to produce a comprehensive MEGA-Map™.
Current Challanges
-
​Diagnostics tests target less than one percent of mutations
-
Precision drugs target only a fraction of potential responders
-
Clinical trials fail because they enroll non-responders
-
Biologic drugs are rarely engineered for potency or safety
-
Bifunctional Therapies require a decade-long development process
Current Approach by other Companies
1. Companies identify variants through the slow process of associating clinical outcomes with genetic changes to produce new Diagnostics. Typically, low throughput approaches are used to validate variants.
2. Companies identify native human proteins as new therapeutics and in rare cases improve them by introducing targeted mutations in a slow iterative process
Our Solutions
-
Diagnostics based upon all mutations
-
Truly precision drugs are selected by testing all mutations​
-
Non-responders are eliminated before expensive clinical trials
-
Rapidly re-design of existing Biologics and engineering of new Biologics with improved efficacy and safety
-
Rapid large-scale screening of 10,000's of multifunction agonists and antagonist chimeras in human cells. (High Content Screening for Biologics)
WHAT WE DO
At Heligenics we produce all genetic variants and test their functional impact en masse in live human cells by delivering Improved Diagnostics, Faster and Better Companion Diagnostics, Truly Precision Clinical Trials, and Novel Biologics and Biobetters
"Directly testing cell & molecular functions is the key to pathology and drug discovery"